Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000875320-26-000206
Filing Date
2026-05-13
Accepted
2026-05-13 16:07:11
Documents
15
Effectiveness Date
2026-05-13

Document Format Files

Seq Description Document Type Size
1 S-8 s-82026plan.htm S-8 150180
2 EX-FILING FEES exfilingfees.htm   iXBRL EX-FILING FEES 19321
3 EX-5.1 a2026s-8_ex51xopinion2026p.htm EX-5.1 7485
4 EX-23.1 a2026s-8_ex231xeyconsent.htm EX-23.1 2977
5 EX-99.1 a2026s-8_ex9912026stockand.htm EX-99.1 103694
6 GRAPHIC image_0a.jpg GRAPHIC 18735
  Complete submission text file 0000875320-26-000206.txt   434744

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT exfilingfees_htm.xml XML 7916
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-295837 | Film No.: 26973272
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)